Cell Therapy Technologies Market

Cell Therapy Technologies Market (Cell Type: Allogeneic and Autologous; Application: Cancer, Autoimmune Diseases, Cardiovascular Disorders, Orthopedic Disorder, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Global Cell Therapy Technologies Market Outlook 2031

  • The global industry was valued at US$ 14.9 Bn in 2022
  • It is projected to expand at a CAGR of 10.5% from 2023 to 2031 and reach US$ 36.0 Bn by the end of 2031

Analysts’ Viewpoint

Prevalence of chronic diseases, including cancer, cardiovascular disorders, and autoimmune conditions, has risen significantly, creating an urgent need for effective treatments. Cell therapies have emerged as a potential solution by offering targeted and personalized approaches, particularly for patients unresponsive to conventional therapies. Surge in patient population and increase in demand for more efficient treatments these diseases are driving the global cell therapy technologies market. Supportive regulatory frameworks have fueled the development and commercialization of cell therapies. Furthermore, increase in awareness and acceptance of cell therapies among healthcare professionals and patients is propelling global cell therapy technologies market demand.

Advancements in cell therapies for the treatment of various chronic diseases offer lucrative opportunities to market players. Companies are focusing on increasing the efficacy and safety of cell therapies to provide improved disease management outcomes for patients.

Cell Therapy Technologies Market

Global Cell Therapy Technologies Market Outlook

The cell therapy technologies market refers to the field of medical treatment that involves the use of living cells to restore or improve the functioning of damaged or diseased tissues and organs. It is a rapidly evolving and promising area of research & development within the broader field of regenerative medicine.

Cell therapy technologies offer the potential to revolutionize the treatment of various diseases, including cancer, cardiovascular disorders, neurological conditions, and autoimmune diseases. Product development in the cell therapy technologies market is characterized by ongoing research and clinical trials to evaluate the safety and efficacy of different cell-based therapies.

Scientists and companies are exploring various approaches, including cell-based immunotherapies, gene therapies, tissue engineering, and ex vivo cell expansion techniques. Significant progress has been made in the development of CAR-T cell therapies for cancer treatment, where immune cells are genetically engineered to recognize and target cancer cells.

Researchers are investigating the potential of stem cell therapies for conditions such as spinal cord injuries, heart diseases, and neurodegenerative disorders. Ongoing research and product development efforts aim to further expand the range of cell therapies available and improve their safety, efficacy, and accessibility.

Rise in Prevalence of Chronic & Degenerative Diseases

Chronic conditions such as cancer, cardiovascular disorders, neurodegenerative diseases, and autoimmune disorders pose significant challenges to the healthcare industry. Conventional treatment approaches often provide limited success in managing or curing these diseases.

Cell therapy, with its potential to repair, regenerate, or replace damaged tissues or organs, offers a promising alternative. The ability of cell therapies to address the underlying cause of diseases and promote long-term healing has garnered significant attention.

Over the years, there have been notable developments in cell therapy technologies to combat chronic and degenerative diseases. For instance, advancements in stem cell research have led to the identification and isolation of various types of stem cells with different therapeutic potential. Researchers are exploring the use of mesenchymal stem cells, induced pluripotent stem cells, and hematopoietic stem cells in developing innovative cell-based therapies.

Thus, rise in prevalence of chronic and degenerative diseases is likely to bolster global cell therapy technologies market size during the forecast period.

Rigorous Efforts by Companies toward Development of Proprietary & Supportive Technologies

Cell therapy, which involves usage of living cells to treat or cure diseases, has emerged as a promising field in regenerative medicine. However, the success of cell therapies depends on the availability of advanced technologies that enable efficient cell manufacturing, characterization, and delivery.

Companies in the cell therapy sector are investing significantly in research & development of proprietary technologies that enhance the efficacy, safety, and scalability of cell therapies. These technologies encompass a wide range of areas, including cell culture systems, cell isolation & expansion methods, cryopreservation techniques, and cell characterization tools.

Development of advanced cell culture systems is a key area of focus. Companies are working on the design and optimization of culture media, growth factors, and bioreactors that provide an ideal environment for cell expansion and maintenance of cell viability and functionality. These proprietary culture systems are aimed at improving cell yields, reducing production costs, and enabling the scalable manufacturing of cell therapies.

Supportive technologies related to cell isolation and purification are also receiving significant attention. Companies are developing novel techniques for isolating specific cell populations from complex mixtures, ensuring the purity and quality of cells used in therapies. These technologies enable the efficient isolation of therapeutic cell types and minimize the risk of contamination or unwanted cell populations.

Cryopreservation technologies are crucial for the long-term storage and transportation of cells. Companies are focused on developing improved cryopreservation methods that maintain cell viability, functionality, and genetic stability during freezing and thawing processes.

These advancements ensure the availability of viable cells at the point of therapy administration, even when there are logistical challenges associated with cell transportation and storage.

Therefore, development of proprietary & supportive technologies is projected to augment global cell therapy technologies market growth.

No Risk of Immune Rejection or Adverse Reactions Bolstering Autologous Segment

In terms of cell type, the autologous segment accounted for the largest global cell therapy technologies market share in 2022. The segment is expected to grow at a higher CAGR during the forecast period.

Autologous cell therapy involves using a patient's own cells for treatment. These therapies offer the advantage of personalized medicine, as they are tailor-made to each patient's specific needs. This eliminates the risk of immune rejection or adverse reactions, as the cells used are derived from the patient's own body.

Rise in Usage of Cell Therapies for Cancer Treatment

Based on application, the cancer segment is projected to dominate the global cell therapy technologies industry during the forecast period. Cancer is a global health challenge affecting millions of people, and there is a significant unmet need for effective treatments.

Cell therapies, such as chimeric antigen receptor (CAR) T-cell therapy, have shown promising results in treating certain types of cancers, particularly hematological malignancies such as leukemia and lymphoma. These therapies involve modifying a patient's own immune cells to recognize and attack cancer cells, offering a potentially curative approach.

Regional Outlook

As per cell therapy technologies market trends, North America is projected to account for the major share of market during the forecast period. The region has a robust and well-established healthcare infrastructure, which includes advanced research facilities, leading academic institutions, and a strong regulatory framework. This supportive ecosystem fosters innovation, accelerates clinical trials, and facilitates the commercialization of cell therapy products.

North America exhibits high prevalence of chronic diseases, including cancer, cardiovascular disorders, and autoimmune conditions, which are key indications targeted by cell therapies. Large patient population and rise in demand for effective treatments contribute to market growth.

Europe has witnessed growing focus on fostering innovation and advancing cell therapy research. The region has strong presence of renowned academic institutions, research organizations, and biotechnology companies, which contribute to the development of cutting-edge cell therapies.

In terms of regulatory advancements, the European Medicines Agency (EMA) has established a regulatory framework specifically tailored for advanced therapy medicinal products (ATMPs), which include cell therapies. This framework, along with the EMA's Priority Medicines (PRIME) scheme, accelerates the assessment and approval processes for promising therapies, promoting their timely availability to patients.

Asia Pacific has a large patient population, particularly in countries such as China and India, which face a high burden of chronic diseases. This provides a substantial market opportunity for cell therapy technologies. Additionally, countries in Asia Pacific have been investing in research & development, fostering collaborations between academia, industry, and government organizations.

Analysis of Key Players

The global cell therapy technologies market is fragmented, with the presence of a number of players. Agilent Technologies, Inc., Merck KGaA, Thermo Fisher Scientific, Inc., Miltenyi Biotech, GE Healthcare, Beckman Coulter, Inc. (Danaher), Sartorius AG, Lonza Group, Terumo Corporation, and Curate Biosciences are the prominent players in the market.

These players have adopted strategies such as mergers & acquisitions, strategic collaborations, and new product launches to expand presence and increase market share.

Key Developments in Global Cell Therapy Technologies Market

  • In January 2023, Curate Biosciences introduced the Curate Cell Processing System to the market, marking its official commercial launch. This groundbreaking system offers improved generation of initial materials for CAR-T cancer therapies and various other cell-based treatment approaches, making it a pioneering solution in the field.
  • In May 2023, New Biologix SA unveiled itself as a technology innovation firm, focusing on the development of a proprietary and groundbreaking platform for advanced engineering of cell lines. This platform specifically targets the manufacturing of gene and cell therapies, addressing significant challenges in the production of recombinant adeno-associated virus (rAAV) vectors. The company's DNA-based platform holds promise in improving the production of advanced therapy medicinal products (ATMPs).

The cell therapy technologies market report profiles the top players based on various factors including a company overview, financial summary, strategies, product portfolio, segments, and recent developments.

Global Cell Therapy Technologies Market Snapshot

Attribute Detail

Size in 2022

US$ 14.9 Bn

Forecast Value in 2031

More than US$ 36.0 Bn

CAGR - 2022-2031

10.5%

Forecast Period

2023-2031

Historical Data Available for

2017-2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Cell Type
    • Allogeneic
      • Blood Cells
      • Others
    • Autologous
      • Human Embryonic Stem Cells
      • Hematopoietic Stem Cells
      • Mesenchymal Stem Cells
      • Other
  • Product
    • Tissue Digestion
      • Instrumentation
      • Consumables & Reagents
    • Cell Selection / Cell Isolation
      • Instrumentation
      • Consumables & Reagents
    • Cell Viability Testing
      • Instrumentation
      • Consumables & Reagents
    • Cell Transduction / Transfection
      • Instrumentation
      • Consumables & Reagents
    • Cell Expansion
      • Instrumentation
      • Consumables & Reagents
    • Quality Control Testing
      • Instrumentation
      • Consumables & Reagents
  • Technology/Method
    • Tissue Digestion
      • Cell Selection / Cell Isolation
      • Immunomagnetic Cell separation (IMS)
      • Fluorescence-activated Cell Sorting (FACS)
      • Density Gradient Centrifugation
      • Microfluidic Cell Separation (MCS)
      • Others
    • Cell Viability Testing
      • Tetrazolium Reduction Assays
      • Protease Viability Marker Assay Concept
      • ATP Assay
      • Real-time Assay
      • Others
    • Cell Transduction/Transfection
      • Cationic-lipid Mediated Transfection
      • Calcium Phosphate Transfection
      • Viral Transfection
      • Electroporation
      • Others
    • Cell Expansion
      • 3D cell culture
      • Roller Bottle Culture
      • Cell Culture Scale-up Systems
      • Spinner Flask Culture
      • Others
    • Quality Control Testing
      • Endotoxin
      • Mycoplasma
      • Others
  • Application
    • Cancer
    • Autoimmune Diseases
    • Cardiovascular Disorders
    • Orthopedic Disorders
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
  • Rest of the World

Countries Covered

  • U.S.
  • Canada
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Agilent Technologies
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Miltenyi Biotech
  • GE Healthcare
  • Beckman Coulter, Inc. (Danaher)
  • Sartorius AG
  • Lonza Group
  • Terumo Corporation
  • Curate Biosciences

Frequently Asked Questions

How big was the global cell therapy technologies market in 2022?

The global industry was valued at US$ 14.9 Bn in 2022

How big will be the cell therapy technologies industry in 2031?

It is projected to reach more than US$ 36.0 Bn by 2031

What will be the CAGR of the cell therapy technologies business during the forecast period?

It is anticipated to expand at a CAGR of 10.5% from 2023 to 2031

Which region will account for major market share of the cell therapy technologies during the forecast period?

North America is expected to account for the largest share from 2023 to 2031

Who are the prominent cell therapy technologies players?

Agilent Technologies, Inc., Merck KGaA, Thermo Fisher Scientific, Inc., Miltenyi Biotech, GE Healthcare, Beckman Coulter, Inc. (Danaher), Sartorius AG, Lonza Group, Terumo Corporation, and Curate Biosciences are the prominent players in the market

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Cell Therapy Technologies Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Market Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Cell Therapy Technologies Market Analysis and Forecast, 2017-2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Technological Advancements

        5.2. Overview of Cell Therapy Product Manufacturing Technologies

        5.3. List of Instruments and Consumables Used For Each of the Technologies

        5.4. Key Mergers & Acquisitions

        5.5. Top 3 Players Operating in the Market Space

    6. Global Cell Therapy Technologies Market Analysis and Forecast, by Cell Type

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Cell Type, 2017-2031

            6.3.1. Allogeneic

                6.3.1.1. Blood Cells

                6.3.1.2. Others

            6.3.2. Autologous

                6.3.2.1. Human Embryonic Stem Cells

                6.3.2.2. Hematopoietic Stem Cells

                6.3.2.3. Mesenchymal Stem Cells

                6.3.2.4. Others

        6.4. Market Attractiveness Analysis, by Cell Type

    7. Global Cell Therapy Technologies Market Analysis and Forecast, by Product

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Product, 2017-2031

            7.3.1. Tissue Digestion

                7.3.1.1. Instrumentation

                7.3.1.2. Consumables & Reagents

            7.3.2. Cell Selection/ Cell Isolation

                7.3.2.1. Instrumentation

                7.3.2.2. Consumables & Reagents

            7.3.3. Cell Viability Testing

                7.3.3.1. Instrumentation

                7.3.3.2. Consumables & Reagents

            7.3.4. Cell Transduction / Transfection

                7.3.4.1. Instrumentation

                7.3.4.2. Consumables & Reagents

            7.3.5. Cell Expansion

                7.3.5.1. Instrumentation

                7.3.5.2. Consumables & Reagents

            7.3.6. Quality Control Testing

                7.3.6.1. Instrumentation

                7.3.6.2. Consumables & Reagents

        7.4. Market Attractiveness Analysis, by Product

    8. Global Cell Therapy Technologies Market Analysis and Forecast, by Technology/Method

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by Technology/Method, 2017-2031

            8.3.1. Tissue Digestion

            8.3.2. Cell Selection/Cell Isolation

                8.3.2.1. Immunomagnetic Cell separation (IMS)

                8.3.2.2. Fluorescence-activated Cell Sorting(FACS)

                8.3.2.3. Density Gradient Centrifugation

                8.3.2.4. Microfluidic Cell Separation (MCS)

                8.3.2.5. Others

            8.3.3. Cell Viability Testing

                8.3.3.1. Tetrazolium Reduction Assay

                8.3.3.2. Protease Viability Marker Assay

                8.3.3.3. ATP Assay

                8.3.3.4. Real-Time Assay

                8.3.3.5. Others

            8.3.4. Cell Transduction/Transfection

                8.3.4.1. Cationic-lipid Mediated Transfection

                8.3.4.2. Calcium Phosphate Transfection

                8.3.4.3. Viral Transfection

                8.3.4.4. Electroporation

                8.3.4.5. Others

            8.3.5. Cell Expansion

                8.3.5.1. 3D Cell Culture

                8.3.5.2. Roller Bottle Culture

                8.3.5.3. Cell Culture Scale-up Systems

                8.3.5.4. Spinner Flask Culture

                8.3.5.5. Others

            8.3.6. Quality Control Testing

                8.3.6.1. Endotoxin

                8.3.6.2. Mycoplasma

                8.3.6.3. Others

        8.4. Market Attractiveness Analysis, by Technology/Method

    9. Global Cell Therapy Technologies Market Analysis and Forecast, by Application

        9.1. Introduction & Definition

        9.2. Key Findings / Developments

        9.3. Market Value Forecast, by Application, 2017-2031

            9.3.1. Cancer

            9.3.2. Autoimmune Diseases

            9.3.3. Cardiovascular Disorders

            9.3.4. Orthopedic Disorders

            9.3.5. Others

        9.4. Market Attractiveness Analysis, by Application

    10. Global Cell Therapy Technologies Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Market Value Forecast, by Region

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa

        10.3. Market Attractiveness Analysis, by Region

    11. North America Cell Therapy Technologies Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Cell Type, 2017-2031

            11.2.1. Allogeneic

                11.2.1.1. Blood Cells

                11.2.1.2. Others

            11.2.2. Autologous

                11.2.2.1. Human Embryonic Stem Cells

                11.2.2.2. Hematopoietic Stem Cells

                11.2.2.3. Mesenchymal Stem Cells

                11.2.2.4. Others

        11.3. Market Value Forecast, by Product, 2017-2031

            11.3.1. Tissue Digestion

                11.3.1.1. Instrumentation

                11.3.1.2. Consumables & Reagents

            11.3.2. Cell Selection/ Cell Isolation

                11.3.2.1. Instrumentation

                11.3.2.2. Consumables & Reagents

            11.3.3. Cell Viability Testing

                11.3.3.1. Instrumentation

                11.3.3.2. Consumables & Reagents

            11.3.4. Cell Transduction / Transfection

                11.3.4.1. Instrumentation

                11.3.4.2. Consumables & Reagents

            11.3.5. Cell Expansion

                11.3.5.1. Instrumentation

                11.3.5.2. Consumables & Reagents

            11.3.6. Quality Control Testing

                11.3.6.1. Instrumentation

                11.3.6.2. Consumables & Reagents

        11.4. Market Value Forecast, by Technology/Method, 2017-2031

            11.4.1. Tissue Digestion

            11.4.2. Cell Selection/Cell Isolation

                11.4.2.1. Immunomagnetic Cell separation (IMS)

                11.4.2.2. Fluorescence-activated Cell Sorting(FACS)

                11.4.2.3. Density Gradient Centrifugation

                11.4.2.4. Microfluidic Cell Separation (MCS)

                11.4.2.5. Others

            11.4.3. Cell Viability Testing

                11.4.3.1. Tetrazolium Reduction Assay

                11.4.3.2. Protease Viability Marker Assay

                11.4.3.3. ATP Assay

                11.4.3.4. Real-Time Assay

                11.4.3.5. Others

            11.4.4. Cell Transduction/Transfection

                11.4.4.1. Cationic-lipid Mediated Transfection

                11.4.4.2. Calcium Phosphate Transfection

                11.4.4.3. Viral Transfection

                11.4.4.4. Electroporation

                11.4.4.5. Others

            11.4.5. Cell Expansion

                11.4.5.1. 3D Cell Culture

                11.4.5.2. Roller Bottle Culture

                11.4.5.3. Cell Culture Scale-up Systems

                11.4.5.4. Spinner Flask Culture

                11.4.5.5. Others

            11.4.6. Quality Control Testing

                11.4.6.1. Endotoxin

                11.4.6.2. Mycoplasma

                11.4.6.3. Others

        11.5. Market Value Forecast, by Application, 2017-2031

            11.5.1. Cancer

            11.5.2. Autoimmune Diseases

            11.5.3. Cardiovascular Disorders

            11.5.4. Orthopedic Disorders

            11.5.5. Others

        11.6. Market Value Forecast, by Country, 2017-2031

            11.6.1. U.S.

            11.6.2. Canada

        11.7. Market Attractiveness Analysis

            11.7.1. By Cell Type

            11.7.2. By Product

            11.7.3. By Technology/Method

            11.7.4. By Application

            11.7.5. By Country

    12. Europe Cell Therapy Technologies Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Cell Type, 2017-2031

            12.2.1. Allogeneic

                12.2.1.1. Blood Cells

                12.2.1.2. Others

            12.2.2. Autologous

                12.2.2.1. Human Embryonic Stem Cells

                12.2.2.2. Hematopoietic Stem Cells

                12.2.2.3. Mesenchymal Stem Cells

                12.2.2.4. Others

        12.3. Market Value Forecast, by Product, 2017-2031

            12.3.1. Tissue Digestion

                12.3.1.1. Instrumentation

                12.3.1.2. Consumables & Reagents

            12.3.2. Cell Selection/ Cell Isolation

                12.3.2.1. Instrumentation

                12.3.2.2. Consumables & Reagents

            12.3.3. Cell Viability Testing

                12.3.3.1. Instrumentation

                12.3.3.2. Consumables & Reagents

            12.3.4. Cell Transduction / Transfection

                12.3.4.1. Instrumentation

                12.3.4.2. Consumables & Reagents

            12.3.5. Cell Expansion

                12.3.5.1. Instrumentation

                12.3.5.2. Consumables & Reagents

            12.3.6. Quality Control Testing

                12.3.6.1. Instrumentation

                12.3.6.2. Consumables & Reagents

        12.4. Market Value Forecast, by Technology/Method, 2017-2031

            12.4.1. Cell Selection/Cell Isolation

                12.4.1.1. Immunomagnetic Cell separation (IMS)

                12.4.1.2. Fluorescence-activated Cell Sorting(FACS)

                12.4.1.3. Density Gradient Centrifugation

                12.4.1.4. Microfluidic Cell Separation (MCS)

                12.4.1.5. Others

            12.4.2. Cell Viability Testing

                12.4.2.1. Tetrazolium Reduction Assay

                12.4.2.2. Protease Viability Marker Assay

                12.4.2.3. ATP Assay

                12.4.2.4. Real-Time Assay

                12.4.2.5. Others

            12.4.3. Cell Transduction/Transfection

                12.4.3.1. Cationic-lipid Mediated Transfection

                12.4.3.2. Calcium Phosphate Transfection

                12.4.3.3. Viral Transfection

                12.4.3.4. Electroporation

                12.4.3.5. Others

            12.4.4. Cell Expansion

                12.4.4.1. 3D Cell Culture

                12.4.4.2. Roller Bottle Culture

                12.4.4.3. Cell Culture Scale-up Systems

                12.4.4.4. Spinner Flask Culture

                12.4.4.5. Others

            12.4.5. Quality Control Testing

                12.4.5.1. Endotoxin

                12.4.5.2. Mycoplasma

                12.4.5.3. Others

        12.5. Market Value Forecast, by Application, 2017-2031

            12.5.1. Cancer

            12.5.2. Autoimmune Diseases

            12.5.3. Cardiovascular Disorders

            12.5.4. Orthopedic Disorders

            12.5.5. Others

        12.6. Market Value Forecast, by Country/Sub-region, 2017-2031

            12.6.1. Germany

            12.6.2. U.K.

            12.6.3. France

            12.6.4. Spain

            12.6.5. Italy

            12.6.6. Rest of Europe

        12.7. Market Attractiveness Analysis

            12.7.1. By Cell Type

            12.7.2. By Product

            12.7.3. By Technology/Method

            12.7.4. By Application

            12.7.5. By Country/Sub-region

    13. Asia Pacific Cell Therapy Technologies Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Cell Type, 2017-2031

            13.2.1. Allogeneic

                13.2.1.1. Blood Cells

                13.2.1.2. Others

            13.2.2. Autologous

                13.2.2.1. Human Embryonic Stem Cells

                13.2.2.2. Hematopoietic Stem Cells

                13.2.2.3. Mesenchymal Stem Cells

                13.2.2.4. Others

        13.3. Market Value Forecast, by Product, 2017-2031

            13.3.1. Tissue Digestion

                13.3.1.1. Instrumentation

                13.3.1.2. Consumables & Reagents

            13.3.2. Cell Selection/ Cell Isolation

                13.3.2.1. Instrumentation

                13.3.2.2. Consumables & Reagents

            13.3.3. Cell Viability Testing

                13.3.3.1. Instrumentation

                13.3.3.2. Consumables & Reagents

            13.3.4. Cell Transduction / Transfection

                13.3.4.1. Instrumentation

                13.3.4.2. Consumables & Reagents

            13.3.5. Cell Expansion

                13.3.5.1. Instrumentation

                13.3.5.2. Consumables & Reagents

            13.3.6. Quality Control Testing

                13.3.6.1. Instrumentation

                13.3.6.2. Consumables & Reagents

        13.4. Market Value Forecast, by Technology/Method, 2017-2031

            13.4.1. Tissue Digestion

            13.4.2. Cell Selection/Cell Isolation

                13.4.2.1. Immunomagnetic Cell separation (IMS)

                13.4.2.2. Fluorescence-activated Cell Sorting(FACS)

                13.4.2.3. Density Gradient Centrifugation

                13.4.2.4. Microfluidic Cell Separation (MCS)

                13.4.2.5. Others

            13.4.3. Cell Viability Testing

                13.4.3.1. Tetrazolium Reduction Assay

                13.4.3.2. Protease Viability Marker Assay

                13.4.3.3. ATP Assay

                13.4.3.4. Real-Time Assay

                13.4.3.5. Others

            13.4.4. Cell Transduction/Transfection

                13.4.4.1. Cationic-lipid Mediated Transfection

                13.4.4.2. Calcium Phosphate Transfection

                13.4.4.3. Viral Transfection

                13.4.4.4. Electroporation

                13.4.4.5. Others

            13.4.5. Cell Expansion

                13.4.5.1. 3D Cell Culture

                13.4.5.2. Roller Bottle Culture

                13.4.5.3. Cell Culture Scale-up Systems

                13.4.5.4. Spinner Flask Culture

                13.4.5.5. Others

            13.4.6. Quality Control Testing

                13.4.6.1. Endotoxin

                13.4.6.2. Mycoplasma

                13.4.6.3. Others

        13.5. Market Value Forecast, by Application, 2017-2031

            13.5.1. Cancer

            13.5.2. Autoimmune Diseases

            13.5.3. Cardiovascular Disorders

            13.5.4. Orthopedic Disorders

            13.5.5. Others

        13.6. Market Value Forecast, by Country/Sub-region, 2017-2031

            13.6.1. China

            13.6.2. Japan

            13.6.3. India

            13.6.4. Australia & New Zealand

            13.6.5. Rest of Asia Pacific

        13.7. Market Attractiveness Analysis

            13.7.1. By Cell Type

            13.7.2. By Product

            13.7.3. By Technology/Method

            13.7.4. By Application

            13.7.5. By Country/Sub-region

    14. Latin America Cell Therapy Technologies Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Cell Type, 2017-2031

            14.2.1. Allogeneic

                14.2.1.1. Blood Cells

                14.2.1.2. Others

            14.2.2. Autologous

                14.2.2.1. Human Embryonic Stem Cells

                14.2.2.2. Hematopoietic Stem Cells

                14.2.2.3. Mesenchymal Stem Cells

                14.2.2.4. Others

        14.3. Market Value Forecast, by Product, 2017-2031

            14.3.1. Tissue Digestion

                14.3.1.1. Instrumentation

                14.3.1.2. Consumables & Reagents

            14.3.2. Cell Selection/ Cell Isolation

                14.3.2.1. Instrumentation

                14.3.2.2. Consumables & Reagents

            14.3.3. Cell Viability Testing

                14.3.3.1. Instrumentation

                14.3.3.2. Consumables & Reagents

            14.3.4. Cell Transduction / Transfection

                14.3.4.1. Instrumentation

                14.3.4.2. Consumables & Reagents

            14.3.5. Cell Expansion

                14.3.5.1. Instrumentation

                14.3.5.2. Consumables & Reagents

            14.3.6. Quality Control Testing

                14.3.6.1. Instrumentation

                14.3.6.2. Consumables & Reagents

        14.4. Market Value Forecast, by Technology/Method, 2017-2031

            14.4.1. Tissue Digestion

            14.4.2. Cell Selection/Cell Isolation

                14.4.2.1. Immunomagnetic Cell separation (IMS)

                14.4.2.2. Fluorescence-activated Cell Sorting(FACS)

                14.4.2.3. Density Gradient Centrifugation

                14.4.2.4. Microfluidic Cell Separation (MCS)

                14.4.2.5. Others

            14.4.3. Cell Viability Testing

                14.4.3.1. Tetrazolium Reduction Assay

                14.4.3.2. Protease Viability Marker Assay

                14.4.3.3. ATP Assay

                14.4.3.4. Real-Time Assay

                14.4.3.5. Others

            14.4.4. Cell Transduction/Transfection

                14.4.4.1. Cationic-lipid Mediated Transfection

                14.4.4.2. Calcium Phosphate Transfection

                14.4.4.3. Viral Transfection

                14.4.4.4. Electroporation

                14.4.4.5. Others

            14.4.5. Cell Expansion

                14.4.5.1. 3D Cell Culture

                14.4.5.2. Roller Bottle Culture

                14.4.5.3. Cell Culture Scale-up Systems

                14.4.5.4. Spinner Flask Culture

                14.4.5.5. Others

            14.4.6. Quality Control Testing

                14.4.6.1. Endotoxin

                14.4.6.2. Mycoplasma

                14.4.6.3. Others

        14.5. Market Value Forecast, by Application, 2017-2031

            14.5.1. Cancer

            14.5.2. Autoimmune Diseases

            14.5.3. Cardiovascular Disorders

            14.5.4. Orthopedic Disorders

            14.5.5. Others

        14.6. Market Value Forecast, by Country/Sub-region, 2017-2031

            14.6.1. Brazil

            14.6.2. Mexico

            14.6.3. Rest of Latin America

        14.7. Market Attractiveness Analysis

            14.7.1. By Cell Type

            14.7.2. By Product

            14.7.3. By Technology/Method

            14.7.4. By Application

            14.7.5. By Country/Sub-region

    15. Middle East & Africa Cell Therapy Technologies Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast, by Cell Type, 2017-2031

            15.2.1. Allogeneic

                15.2.1.1. Blood Cells

                15.2.1.2. Others

            15.2.2. Autologous

                15.2.2.1. Human Embryonic Stem Cells

                15.2.2.2. Hematopoietic Stem Cells

                15.2.2.3. Mesenchymal Stem Cells

                15.2.2.4. Others

        15.3. Market Value Forecast, by Product, 2017-2031

            15.3.1. Tissue Digestion

                15.3.1.1. Instrumentation

                15.3.1.2. Consumables & Reagents

            15.3.2. Cell Selection/ Cell Isolation

                15.3.2.1. Instrumentation

                15.3.2.2. Consumables & Reagents

            15.3.3. Cell Viability Testing

                15.3.3.1. Instrumentation

                15.3.3.2. Consumables & Reagents

            15.3.4. Cell Transduction / Transfection

                15.3.4.1. Instrumentation

                15.3.4.2. Consumables & Reagents

            15.3.5. Cell Expansion

                15.3.5.1. Instrumentation

                15.3.5.2. Consumables & Reagents

            15.3.6. Quality Control Testing

                15.3.6.1. Instrumentation

                15.3.6.2. Consumables & Reagents

        15.4. Market Value Forecast, by Technology/Method, 2017-2031

            15.4.1. Tissue Digestion

            15.4.2. Cell Selection/Cell Isolation

                15.4.2.1. Immunomagnetic Cell separation (IMS)

                15.4.2.2. Fluorescence-activated Cell Sorting(FACS)

                15.4.2.3. Density Gradient Centrifugation

                15.4.2.4. Microfluidic Cell Separation (MCS)

                15.4.2.5. Others

            15.4.3. Cell Viability Testing

                15.4.3.1. Tetrazolium Reduction Assay

                15.4.3.2. Protease Viability Marker Assay

                15.4.3.3. ATP Assay

                15.4.3.4. Real-Time Assay

                15.4.3.5. Others

            15.4.4. Cell Transduction/Transfection

                15.4.4.1. Cationic-lipid Mediated Transfection

                15.4.4.2. Calcium Phosphate Transfection

                15.4.4.3. Viral Transfection

                15.4.4.4. Electroporation

                15.4.4.5. Others

            15.4.5. Cell Expansion

                15.4.5.1. 3D Cell Culture

                15.4.5.2. Roller Bottle Culture

                15.4.5.3. Cell Culture Scale-up Systems

                15.4.5.4. Spinner Flask Culture

                15.4.5.5. Others

            15.4.6. Quality Control Testing

                15.4.6.1. Endotoxin

                15.4.6.2. Mycoplasma

                15.4.6.3. Others

        15.5. Market Value Forecast, by Application, 2017-2031

            15.5.1. Cancer

            15.5.2. Autoimmune Diseases

            15.5.3. Cardiovascular Disorders

            15.5.4. Orthopedic Disorders

            15.5.5. Others

        15.6. Market Value Forecast, by Country/Sub-region, 2017-2031

            15.6.1. GCC Countries

            15.6.2. South Africa

            15.6.3. Rest of Middle East & Africa

        15.7. Market Attractiveness Analysis

            15.7.1. By Cell Type

            15.7.2. By Product

            15.7.3. By Technology/Method

            15.7.4. By Application

            15.7.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Share Analysis, by Company, 2022

        16.2. Company Profiles

            16.2.1. Agilent Technologies

                16.2.1.1. Company Overview

                16.2.1.2. Financial Overview

                16.2.1.3. Product Portfolio

                16.2.1.4. Business Strategies

                16.2.1.5. Recent Developments

            16.2.2. Merck KGaA

                16.2.2.1. Company Overview

                16.2.2.2. Financial Overview

                16.2.2.3. Product Portfolio

                16.2.2.4. Business Strategies

                16.2.2.5. Recent Developments

            16.2.3. Thermo Fisher Scientific, Inc.

                16.2.3.1. Company Overview

                16.2.3.2. Financial Overview

                16.2.3.3. Product Portfolio

                16.2.3.4. Business Strategies

                16.2.3.5. Recent Developments

            16.2.4. Miltenyi Biotech

                16.2.4.1. Company Overview

                16.2.4.2. Financial Overview

                16.2.4.3. Product Portfolio

                16.2.4.4. Business Strategies

                16.2.4.5. Recent Developments

            16.2.5. GE Healthcare (General Electric Company)

                16.2.5.1. Company Overview

                16.2.5.2. Financial Overview

                16.2.5.3. Product Portfolio

                16.2.5.4. Business Strategies

                16.2.5.5. Recent Developments

            16.2.6. Beckman Coulter, Inc. (Danaher)

                16.2.6.1. Company Overview

                16.2.6.2. Financial Overview

                16.2.6.3. Product Portfolio

                16.2.6.4. Business Strategies

                16.2.6.5. Recent Developments

            16.2.7. Sartorius AG

                16.2.7.1. Company Overview

                16.2.7.2. Financial Overview

                16.2.7.3. Product Portfolio

                16.2.7.4. Business Strategies

                16.2.7.5. Recent Developments

            16.2.8. Lonza Group

                16.2.8.1. Company Overview

                16.2.8.2. Financial Overview

                16.2.8.3. Product Portfolio

                16.2.8.4. Business Strategies

                16.2.8.5. Recent Developments

            16.2.9. Terumo Corporation

                16.2.9.1. Company Overview

                16.2.9.2. Financial Overview

                16.2.9.3. Product Portfolio

                16.2.9.4. Business Strategies

                16.2.9.5. Recent Developments

            16.2.10. Curate Biosciences

                16.2.10.1. Company Overview

                16.2.10.2. Financial Overview

                16.2.10.3. Product Portfolio

                16.2.10.4. Business Strategies

                16.2.10.5. Recent Developments

    List of Tables

    Table 01: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Type, 2017-2031

    Table 02: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Allogeneic, 2017-2031

    Table 03: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Autologous, 2017-2031

    Table 04: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Product, 2017-2031

    Table 05: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

    Table 06: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031

    Table 07: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

    Table 08: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031

    Table 09: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

    Table 10: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

    Table 04: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Technology/Method, 2017-2031

    Table 11: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

    Table 12: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031

    Table 13: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

    Table 14: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031

    Table 15: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

    Table 16: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

    Table 17: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 18: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Region, 2017-2031

    Table 19: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Country, 2017-2031

    Table 20: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Type, 2017-2031

    Table 21: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Allogeneic, 2017-2031

    Table 22: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Autologous, 2017-2031

    Table 23: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Product, 2017-2031

    Table 24: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

    Table 25: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031

    Table 26: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

    Table 27: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031

    Table 28: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

    Table 29: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

    Table 23: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Technology/Method 2017-2031

    Table 30: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

    Table 31: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031

    Table 32: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

    Table 33: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031

    Table 34: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

    Table 35: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

    Table 36: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 37: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 38: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Type, 2017-2031

    Table 39: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Allogeneic, 2017-2031

    Table 40: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Autologous, 2017-2031

    Table 41: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Product, 2017-2031

    Table 42: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

    Table 43: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation by Product, 2017-2031

    Table 44: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

    Table 45: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection by Product, 2017-2031

    Table 46: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

    Table 47: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

    Table 48: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Technology/Method, 2017-2031

    Table 49: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

    Table 50: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031

    Table 51: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

    Table 52: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031

    Table 53: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

    Table 54: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

    Table 55: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 56: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 57: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Type, 2017-2031

    Table 58: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Allogeneic, 2017-2031

    Table 59: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Autologous, 2017-2031

    Table 60: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Product, 2017-2031

    Table 61: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

    Table 62: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/ Cell Isolation by Product, 2017-2031

    Table 63: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

    Table 64: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection by Product, 2017-2031

    Table 65: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

    Table 66: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

    Table 67: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Technology/Method, 2017-2031

    Table 68: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

    Table 69: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031

    Table 70: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

    Table 71: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031

    Table 72: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

    Table 73: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

    Table 74: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 75: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 76: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Type, 2017-2031

    Table 77: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Allogeneic, 2017-2031

    Table 78: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Autologous, 2017-2031

    Table 79: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Product, 2017-2031

    Table 80: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

    Table 81: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/ Cell Isolation by Product, 2017-2031

    Table 82: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

    Table 83: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction /Transfection, 2017-2031

    Table 84: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

    Table 85: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

    Table 86: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Technology/Method, 2017-2031

    Table 87: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

    Table 88: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031

    Table 89: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

    Table 90: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031

    Table 91: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

    Table 92: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

    Table 93: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 94: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 95: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Type, 2017-2031

    Table 96: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Allogeneic, 2017-2031

    Table 97: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Autologous, 2017-2031

    Table 98: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Product, 2017-2031

    Table 99: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

    Table 100: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/ Cell Isolation by Product, 2017-2031

    Table 101: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

    Table 102: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction /Transfection, 2017-2031

    Table 103: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

    Table 104: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

    Table 105: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Technology/Method 2017-2031

    Table 106: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

    Table 107: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031

    Table 108: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

    Table 109: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031

    Table 110: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

    Table 111: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

    Table 112: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031

    List of Figures

    Figure 01: Global Cell Therapy Technologies Market Snapshot

    Figure 02: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, 2017-2031

    Figure 03: Global Cell Therapy Technologies Market Value Share, by Technology/Method, 2022

    Figure 04: Global Cell Therapy Technologies Market Value Share, by Product, 2022

    Figure 05: Global Cell Therapy Technologies Market Value Share, by Cell Type, 2022

    Figure 06: Global Cell Therapy Technologies Market Value Share, by Application, 2022

    Figure 07: Global Cell Therapy Technologies Market Value Share, by Region, 2022

    Figure 08: Global Cell Therapy Technologies Market Value Share Analysis, by Cell Type, 2022 and 2031

    Figure 09: Global Cell Therapy Technologies Market Attractiveness Analysis, by Cell Type, 2023-2031

    Figure 10: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Allogeneic, 2017-2031

    Figure 11: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Autologous, 2017-2031

    Figure 12: Global Cell Therapy Technologies Market Value Share Analysis, by Technology/Method, 2022 and 2031

    Figure 13: Global Cell Therapy Technologies Market Attractiveness Analysis, by Technology/Method, 2023-2031

    Figure 14: Global Cell Therapy Technologies Market Value Share Analysis, by Product, 2022 and 2031

    Figure 15: Global Cell Therapy Technologies Market Attractiveness Analysis, by Product, 2023-2031

    Figure 16: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Tissue Digestion, 2017-2031

    Figure 17: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cell Selection/Cell Isolation, 2017-2031

    Figure 18: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cell Viability Testing, 2017-2031

    Figure 19: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cell Transduction/Transfection, 2017-2031

    Figure 20: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cell Expansion, 2017-2031

    Figure 21: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), By Quality Control Testing , 2017-2031

    Figure 22: Global Cell Therapy Technologies Market Value Share Analysis, by Technology/Method, 2022 and 2031

    Figure 23: Global Cell Therapy Technologies Market Attractiveness Analysis, by Technology/Method, 2023-2031

    Figure 24: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Tissue Digestion, 2017-2031

    Figure 25: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cell Selection/Cell Isolation, 2017-2031

    Figure 26: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cell Viability Testing, 2017-2031

    Figure 27: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cell Transduction/Transfection, 2017-2031

    Figure 28: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cell Expansion, 2017-2031

    Figure 29: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Quality Control Testing, 2017-2031

    Figure 30: Global Cell Therapy Technologies Market Value Share Analysis, by Application, 2022 and 2031

    Figure 31: Global Cell Therapy Technologies Market Attractiveness Analysis, by Application, 2023-2031

    Figure 32: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cancer, 2017-2031

    Figure 33: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Autoimmune Diseases, 2017-2031

    Figure 34: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cardiovascular Disorders, 2017-2031

    Figure 35: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Orthopedic Disorders, 2017-2031

    Figure 36: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2017-2031

    Figure 37: Global Cell Therapy Technologies Market Value Share, by Region, 2022 and 2031

    Figure 38: Global Cell Therapy Technologies Market Attractiveness Analysis, by Region, 2023-2031

    Figure 39: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 40: North America Cell Therapy Technologies Market Value Share (%) Analysis, by Country, 2022 and 2031

    Figure 41: North America Cell Therapy Technologies Market Attractiveness Analysis, by Country, 2023-2031

    Figure 42: North America Cell Therapy Technologies Market Value Share Analysis, by Cell Type, 2022 and 2031

    Figure 43: North America Cell Therapy Technologies Market Attractiveness Analysis, by Cell Type, 2023-2031

    Figure 44: North America Cell Therapy Technologies Market Value Share Analysis, by Product, 2022 and 2031

    Figure 45: North America Cell Therapy Technologies Market Attractiveness Analysis, by Product, 2023-2031

    Figure 46: North America Cell Therapy Technologies Market Value Share Analysis, by Technology/ Method, 2022 and 2031

    Figure 47: North America Cell Therapy Technologies Market Attractiveness Analysis, by Technology/ Method, 2023-2031

    Figure 48: North America Cell Therapy Technologies Market Value Share Analysis, by Application, 2022 and 2031

    Figure 49: North America Cell Therapy Technologies Market Attractiveness Analysis, by Application, 2023-2031

    Figure 50: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 51: Europe Cell Therapy Technologies Market Value Share (%) Analysis, by Country/Sub-region, 2022 and 2031

    Figure 52: Europe Cell Therapy Technologies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 53: Europe Cell Therapy Technologies Market Value Share Analysis, by Cell Type, 2022 and 2031

    Figure 54: Europe Cell Therapy Technologies Market Attractiveness Analysis, by Cell Type, 2023-2031

    Figure 55: Europe Cell Therapy Technologies Market Value Share Analysis, by Product, 2022 and 2031

    Figure 56: Europe Cell Therapy Technologies Market Attractiveness Analysis, by Product, 2023-2031

    Figure 57: Europe Cell Therapy Technologies Market Value Share Analysis, by Technology/Method, 2022 and 2031

    Figure 58: Europe Cell Therapy Technologies Market Attractiveness Analysis, by Technology/Method, 2023-2031

    Figure 59: Europe Cell Therapy Technologies Market Value Share Analysis, by Application, 2022 and 2031

    Figure 60: Europe Cell Therapy Technologies Market Attractiveness Analysis, by Application, 2023-2031

    Figure 61: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 62: Asia Pacific Cell Therapy Technologies Market Value Share (%) Analysis, by Country/Sub-region, 2022 and 2031

    Figure 63: Asia Pacific Cell Therapy Technologies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 64: Asia Pacific Cell Therapy Technologies Market Value Share Analysis, by Cell Type, 2022 and 2031

    Figure 65: Asia Pacific Cell Therapy Technologies Market Attractiveness Analysis, by Cell Type, 2023-2031

    Figure 66: Asia Pacific Cell Therapy Technologies Market Value Share Analysis, by Product, 2022 and 2031

    Figure 67: Asia Pacific Cell Therapy Technologies Market Attractiveness Analysis, by Product,, 2023-2031

    Figure 68: Asia Pacific Cell Therapy Technologies Market Value Share Analysis, by Technology/Method, 2022 and 2031

    Figure 69: Asia Pacific Cell Therapy Technologies Market Attractiveness Analysis, by Technology/Method, 2023-2031

    Figure 70: Asia Pacific Cell Therapy Technologies Market Value Share Analysis, by Application, 2022 and 2031

    Figure 71: Asia Pacific Cell Therapy Technologies Market Attractiveness Analysis, by Application, 2023-2031

    Figure 72: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 73: Latin America Cell Therapy Technologies Market Value Share (%) Analysis, by Country/Sub-region, 2022 and 2031

    Figure 74: Latin America Cell Therapy Technologies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 75: Latin America Cell Therapy Technologies Market Value Share Analysis, by Cell Type, 2022 and 2031

    Figure 76: Latin America Cell Therapy Technologies Market Attractiveness Analysis, by Cell Type, 2023-2031

    Figure 77: Latin America Cell Therapy Technologies Market Value Share Analysis, by Product, 2022 and 2031

    Figure 78: Latin America Cell Therapy Technologies Market Attractiveness Analysis, by Product,, 2023-2031

    Figure 79: Latin America Cell Therapy Technologies Market Value Share Analysis, by Technology/Method, 2022 and 2031

    Figure 80: Latin America Cell Therapy Technologies Market Attractiveness Analysis, by Technology/Method, 2023-2031

    Figure 81: Latin America Cell Therapy Technologies Market Value Share Analysis, by Application, 2022 and 2031

    Figure 82: Latin America Cell Therapy Technologies Market Attractiveness Analysis, by Application, 2023-2031

    Figure 83: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 84: Middle East & Africa Cell Therapy Technologies Market Value Share (%) Analysis, by Country/Sub-region, 2022 & 2031

    Figure 85: Middle East & Africa Cell Therapy Technologies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 86: Middle East & Africa Cell Therapy Technologies Market Value Share Analysis, by Cell Type, 2022 and 2031

    Figure 87: Middle East & Africa Cell Therapy Technologies Market Attractiveness Analysis, by Cell Type, 2023-2031

    Figure 88: Middle East & Africa Cell Therapy Technologies Market Value Share Analysis, by Product, 2022 and 2031

    Figure 89: Middle East & Africa Cell Therapy Technologies Market Attractiveness Analysis, by Product, 2023-2031

    Figure 90: Middle East & Africa Cell Therapy Technologies Market Value Share Analysis, by Technology/Method, 2022 and 2031

    Figure 91: Middle East & Africa Cell Therapy Technologies Market Attractiveness Analysis, by Technology/Method, 2023-2031

    Figure 92: Middle East & Africa Cell Therapy Technologies Market Value Share Analysis, by Application, 2022 and 2031

    Figure 93: Middle East & Africa Cell Therapy Technologies Market Attractiveness Analysis, by Application, 2023-2031

    Figure 94: Company Share Analysis

Copyright © Transparency Market Research, Inc. All Rights reserved